Fatigue News and Research

RSS

Adult sleepwalking may induce violent behaviors and affect health-related quality of life

A new study found that adult sleepwalking is a potentially serious condition that may induce violent behaviors and affect health-related quality of life.

1 Mar 2013

Fatigue before cancer treatment impacts fatigue afterwards

Individuals who survive cancer are significantly more likely to develop severe persistent fatigue a year after treatment if they were fatigued before and shortly after treatment, indicate Dutch study findings.

28 Feb 2013

Taiho Pharmaceutical seeks Japanese approval for TAS-102 to treat colorectal cancer

Taiho Pharmaceutical Co., Ltd. announced on February 27 that it submitted an application on February 26 for approval of the manufacture and marketing of the novel oral nucleoside antitumor agent TAS-102 (combination of trifluorothymidine (FTD) and tipiracil hydrochloride (TPI)) to the Japanese Ministry of Health, Labor and Welfare.

27 Feb 2013

New journal aims to address fatigue in medical illnesses and specific environmental conditions

With peer-reviewed articles on fatigue having increased 90% over the past decade - and nearly 1,000 papers on the topic published in 2011 alone - the time is right for Routledge's new journal, Fatigue: Biomedicine, Health & Behavior.

27 Feb 2013

Learned helplessness role in inflammatory polyarthritis revealed

Learned helplessness is a modifiable risk factor that can significantly influence disease outcome in patients with inflammatory polyarthritis, UK clinicians believe.

26 Feb 2013

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Complementary medicines include products containing herbs, vitamins, minerals, nutritional supplements, homoeopathic medicines, certain aromatherapy products and traditional Chinese medicines. For this reason they are also called herbal, natural or alternative medicines.

26 Feb 2013

Bayer receives FDA approval for Stivarga to treat advanced gastrointestinal stromal tumors

The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved treatments for this disease.

26 Feb 2013

Scientists identify mechanosensitive cellular signaling pathway in myofibroblasts

Pulmonary fibrosis is a scarring or thickening of the lungs that causes shortness of breath, a dry cough, fatigue, chest discomfort, weight loss, a decrease in the ability of the lungs to transmit oxygen to the blood stream, and, eventually, heart failure.

24 Feb 2013

Genentech receives FDA approval for Kadcyla to treat HER2-positive metastatic breast cancer

The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new therapy for patients with HER2-positive, late-stage (metastatic) breast cancer.

23 Feb 2013

Study shows how hyperparathyroidism affects people of different racial backgrounds

Unusually high calcium levels in the blood can almost always be traced to primary hyperparathyroidism, an undertreated, underreported condition that affects mainly women and the elderly, according to a new study by UCLA researchers.

22 Feb 2013

Researchers suggest that fibromyalgia is a spectrum disorder

20 Feb 2013

Therapy to ease QOL issues improves patients' sense of well-being during cancer treatment

Therapy to ease stress, fatigue and other quality of life issues significantly improves patients' sense of well-being during cancer treatment, new Mayo Clinic research shows. Patients who kept to their standard routines showed a decline in quality-of-life measures, the study found. The findings are published this month in Cancer.

19 Feb 2013

Fibromyalgia prevalence is 2.1% of the general population in Germany

Researchers have determined that fibromyalgia prevalence is 2.1% of the general population in Germany. Results appearing in Arthritis Care & Research, a journal published by Wiley on behalf of the American College of Rheumatology (ACR), suggest that fibromyalgia is a spectrum disorder rather than a categorical illness. Additionally, a number of fibromyalgia cases in the general population satisfy proposed criteria for physical symptom disorder—the presence of one or more physical symptoms that impair function, which cannot be explained by another clinical or psychiatric illness.

19 Feb 2013

Positive new data from Genzyme’s eliglustat tartrate Phase 3 studies on Gaucher disease type 1

Genzyme, a Sanofi company, today announced positive new data from the Phase 3 ENGAGE and ENCORE studies of eliglustat tartrate, its investigational oral therapy for Gaucher disease type 1.

15 Feb 2013

LASAG trial for severe influenza initiated

...

12 Feb 2013

Selumetinib shows high response rate for patients with low-grade serous ovarian cancer

Low-grade serous ovarian cancer is less common and aggressive than the high-grade variety, yet exceptionally difficult to treat when frontline therapy fails.

11 Feb 2013

Wichita State associate professor writes two books about flu

The flu: It's a popular topic of conversation lately, as most people probably know someone who has gotten sick this winter. But for Wichita State associate professor George Dehner, the flu is a year-round focus. Dehner, who teaches world and environmental history, recently wrote two books about the flu.

11 Feb 2013

Fatigue News and Research

Adult sleepwalking may induce violent behaviors and affect health-related quality of life

Fatigue before cancer treatment impacts fatigue afterwards

Taiho Pharmaceutical seeks Japanese approval for TAS-102 to treat colorectal cancer

New journal aims to address fatigue in medical illnesses and specific environmental conditions

Learned helplessness role in inflammatory polyarthritis revealed

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Bayer receives FDA approval for Stivarga to treat advanced gastrointestinal stromal tumors

Scientists identify mechanosensitive cellular signaling pathway in myofibroblasts

Genentech receives FDA approval for Kadcyla to treat HER2-positive metastatic breast cancer

Study shows how hyperparathyroidism affects people of different racial backgrounds

Researchers suggest that fibromyalgia is a spectrum disorder

Therapy to ease QOL issues improves patients' sense of well-being during cancer treatment

Fibromyalgia prevalence is 2.1% of the general population in Germany

Positive new data from Genzyme’s eliglustat tartrate Phase 3 studies on Gaucher disease type 1

LASAG trial for severe influenza initiated

Selumetinib shows high response rate for patients with low-grade serous ovarian cancer

Wichita State associate professor writes two books about flu

Celgene's Pomalyst receives FDA approval for treatment of multiple myeloma

Four-step process delivers specific, reliable clinical rules

NSU-COM to hold grand opening for America's first Institute for Neuro Immune Medicine

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News